Generation Bio Co. announced that Matthew Norkunas, has been appointed as chief financial officer. Dr. Norkunas most recently served as CFO at SomaLogic Inc., a Colorado-based biotech that uses a proprietary protein scan to evaluate health and assess disease risk. Prior to that, Dr. Norkunas was senior equity analyst at Marsico Capital Management, where he served as the firm’s primary health care investment specialist.